Aspira Pathlab & Diagnostics L Share Price

Aspira Pathlab & Diagnostics Limited is an India-based company, which is engaged in the business of running, owning, managing, and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The Company carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company's tests include pathology test, sonography, x-ray, and radiology. Its pathology tests include Influenza (Flu) Panel with H3N2, Blood chromosome analysis, Filmarray multiplex PCR(BIOFIRE) Pneumonia Panel Plus, Polycystic Ovarian Syndrome (PCOS) 2, Typhoid PCR, Dengue-Chikungunya-Malaria multiplex PCR, Vitamin And TSH, Fever screening profile-2, and others.As of 14 Jun 2026, Aspira Pathlab & Diagnostics L share price is ₹120.00. The stock opened at ₹115.85, compared to its previous close of ₹118.20. During today's trading session, Aspira Pathlab & Diagnostics L share price moved in the range of ₹115.85 to ₹120.00, with an average price of ₹117.92 for the day. Looking at its last 52-week, the stock has touched a low of ₹115.85 and a high of ₹120.00.

The market capitalization of Aspira Pathlab & Diagnostics L is ₹124 Crs, with a P/E ratio of 51.5 and a dividend yield of 0.00%.